Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Cypros technology for prevention of organ transplant rejection covered under U.S. patent

June 17, 1997

ID Vaccine and the University of British Columbia collaborate on bacterial vaccines

June 16, 1997

Roche seeks FDA approval for humanized antibody

June 16, 1997

Update on Alpha-Beta's acquisition and Betafectin trial results timeline

June 11, 1997

New influenza vaccine prepared by Yissum

June 6, 1997

5-LO inhibitor improves transplant preservation injury

June 5, 1997

SANG-35 bioequivalent to Neoral in healthy volunteers

June 5, 1997

IL-10 pretreatment of transplant recipients prolongs allograft survival

June 4, 1997

Mechanism of antiproliferative activity of SP-100030 defined

June 4, 1997

Dietary amino acids enhance allograft survival in rats

June 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...